More Polynovo Limited news
Polynovo LimitedASX: PNV

Further US Sales for NovoSorb BTM

Sep 14, 2017 at 2:32 AM EDT · Issued by Polynovo Limited

Filed with ASX · Sep 14, 2017 at 2:32 AM EDT

On 6ix: 6ix.com/news/further-us-sales-for-novosorb-btm

Watch Polynovo's latest call↗Polynovo (ASX:PNV) Q4 2026 Earnings Call · Replay · Aug 25Read the transcript of Polynovo (ASX:PNV) Q4 2026 Earnings Call↗

Polynovo Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Polynovo Limited on 6ix

Story so far

  • Final Patient Treated in NovoSorb BTM Clinical TrialFeb 11, 2016
  • Successful Clinical Trial Outcomes for NovoSorb BTMFeb 11, 2016
  • NovoSorb BTM Burn TrialFeb 11, 2016

Earlier from Polynovo

  • First US Sales of BTM NovosorbSep 1, 2017
  • Annual Report to shareholders and Appendix 4EAug 24, 2017
  • Business update and earnings guidanceMay 19, 2017
  • Research project collaboration with Beta Cell TechnologiesMay 11, 2017
  • Additional Success US BTM useFeb 26, 2017

Later from Polynovo

  • Placement and Share Purchase PlanSep 24, 2017
  • PolyNovos Israel Market EntryOct 4, 2017
  • New Sales and Repeat Orders in the USOct 11, 2017
  • PolyNovo signs MOU for global breast partnershipOct 15, 2017
  • PolyNovo Announces Breast Device Development AgreementJan 17, 2018
All Polynovo news releases↗

Follow Polynovo into a list and get an email when it puts out news.

Follow Polynovo
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer